Compositions comprising ZD6126 together with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damaging activity for treating e.g. colorectal cancer

Details for Australian Patent Application No. 2004248968 (hide)

Owner Angiogene Pharmaceuticals Limited

Inventors Ryan, Anderson Joseph

Agent Davies Collison Cave

Pub. Number AU-A-2004248968

PCT Pub. Number WO2004/112801

Priority 0314097.7 18.06.03 GB; 0316181.7 10.07.03 GB

Filing date 18 June 2004

Wipo publication date 29 December 2004

International Classifications

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/112801 Priority application(s): WO2004/112801

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004248970-Motion assisting apparatus for flying objects

2004248967-Radiation applicator for microwave medical treatment